Showing results (991-1000 of 3,150) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|February 9, 2021
Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profilingJohanna Schaffenrath, Tania Wyss, Liqun He, et al.Neuro-Oncology|February 13, 2021
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6qLorena V Baroni, Lakshmikirupa Sundaresan, Ayala Heled, et al.Neuro-Oncology|February 18, 2021
Response assessment during chemoradiation using a hypercellular/hyperperfused imaging phenotype predicts survival in patients with newly diagnosed glioblastomaMichelle M Kim, Madhava P Aryal, Yilun Sun, et al.Neuro-Oncology|February 24, 2021
Tumor metabolism and neurocognition in CNS lymphomaHuimin Geng, Mazie Tsang, Lakshmipriya Subbaraj, et al.Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.Neuro-Oncology|September 25, 2019
Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy studyNiels Verburg, Thomas Koopman, Maqsood M Yaqub, et al.Neuro-Oncology|September 11, 2019
Immunotherapy for pediatric brain tumors: past and presentJessica B Foster, Peter J Madsen, Meenakshi Hegde, et al.Neuro-Oncology|October 23, 2018
Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?E Antonio Chiocca, Farshad Nassiri, Justin Wang, et al.Neuro-Oncology|December 22, 2021
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)Sarah E S Leary, Lindsay Kilburn, J Russell Geyer, et al.Neuro-Oncology|December 21, 2021
Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastomaYahaya A Yabo, Simone P Niclou, Anna GolebiewskaPageof 315